We are live on ! Find out more
OGEN icon

Oragenics
OGEN

13 hedge funds and large institutions have $62.2K invested in Oragenics in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more capital inflows, than outflows

Capital inflows: $70.2K | Capital outflows: $41.7K

0.62% more ownership

Funds ownership: 2.33% → 2.95% (+0.62%)

0% more funds holding

Funds holding: 13 → 13 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HRT Financial
HRT Financial
New York
+$26.3K
2
GWM
GSB Wealth Management
Connecticut
+$19K
3
Lionsbridge Wealth Management
Lionsbridge Wealth Management
Florida
+$9.43K
4
Virtu Financial
Virtu Financial
New York
+$8.18K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.98K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$23.4K
2
Citadel Advisors
Citadel Advisors
Florida
-$17.2K
3
UBS Group
UBS Group
Switzerland
-$1.03K
4
Osaic Holdings
Osaic Holdings
Arizona
-$28

OGEN Hedge Fund Activity: Q3 2024 in Review

13 of the 6,985 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2024, worth a combined $62.2K — down 54% from $136K a quarter earlier.

Fund positioning in OGEN was balanced in Q3 2024: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 0 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $26.3K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $23.4K sold.

  • 13 institutional investors held Oragenics (OGEN) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $62.2K of Oragenics stock for Q3 2024, down 54% quarter-over-quarter.
  • 4 funds opened new Oragenics positions in Q3 2024 and 4 closed out, a net change of 0 holders.
  • The largest Oragenics buyer in Q3 2024 was HRT Financial, an estimated $26.3K added.
  • The largest Oragenics seller in Q3 2024 was Renaissance Technologies, an estimated $23.4K sold.

Based on aggregated 13F filings for Q3 2024.